Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4099819
Max Phase: Preclinical
Molecular Formula: C49H85Cl6FN6O12
Molecular Weight: 963.20
Molecule Type: Small molecule
Associated Items:
ID: ALA4099819
Max Phase: Preclinical
Molecular Formula: C49H85Cl6FN6O12
Molecular Weight: 963.20
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cl.Cl.Cl.Cl.Cl.Cl.NC[C@H]1O[C@H](O[C@H]2[C@H](OCCCCCCCCCCCCN3CC[C@@H](c4ccc(F)cc4)[C@H](COc4ccc5c(c4)OCO5)C3)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O
Standard InChI: InChI=1S/C49H79FN6O12.6ClH/c50-31-13-11-29(12-14-31)33-17-19-56(25-30(33)27-62-32-15-16-38-39(21-32)64-28-63-38)18-9-7-5-3-1-2-4-6-8-10-20-61-47-45(67-48-36(54)23-37(58)40(24-51)65-48)34(52)22-35(53)46(47)68-49-44(60)42(55)43(59)41(26-57)66-49;;;;;;/h11-16,21,30,33-37,40-49,57-60H,1-10,17-20,22-28,51-55H2;6*1H/t30-,33-,34-,35+,36+,37-,40+,41+,42-,43+,44+,45+,46-,47-,48+,49+;;;;;;/m0....../s1
Standard InChI Key: JRFAONYZBRYXPZ-LSFXTAMMSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 963.20 | Molecular Weight (Monoisotopic): 962.5740 | AlogP: 1.68 | #Rotatable Bonds: 24 |
Polar Surface Area: 288.10 | Molecular Species: BASE | HBA: 18 | HBD: 9 |
#RO5 Violations: 3 | HBA (Lipinski): 18 | HBD (Lipinski): 14 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 12.66 | CX Basic pKa: 9.94 | CX LogP: 1.66 | CX LogD: -7.59 |
Aromatic Rings: 2 | Heavy Atoms: 68 | QED Weighted: 0.07 | Np Likeness Score: 0.45 |
1. Yang X, Goswami S, Gorityala BK, Domalaon R, Lyu Y, Kumar A, Zhanel GG, Schweizer F.. (2017) A Tobramycin Vector Enhances Synergy and Efficacy of Efflux Pump Inhibitors against Multidrug-Resistant Gram-Negative Bacteria., 60 (9): [PMID:28399372] [10.1021/acs.jmedchem.7b00156] |
Source(1):